A (des)informação sobre medicamentos: o duplo padrão de conduta das empresas farmacêuticas

Barros, José Augusto Cabral de

doi:10.1590/s0102-311x2000000200012

Cited by 31 publications

(26 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It is worthy to consider that the content of these materials is provided to their editors by the pharmaceutical companies themselves. Barros (2000) developed a comparative study between the information contained at Physicians' Desk Reference (PDR), corresponding to Brazilian DEF, and Drug Information for the Health Care Professional (USP-DI), both from United States, with those presented, for the same products, in the Brazilian compendium. The data analysis has pointed to deficiencies of qualitative and quantitative order in the information available at DEF, reinforcing the idea that pharmaceutical specialties compendiums should not be The results obtained are in accordance with similar studies developed at Southeastern Michigan, in Québec, in Hong Kong, in Galicia and in Switzerland, in which the most mentioned publication was also a pharmaceutical specialties compendium (Poirier, Ascione, 1980;Mailhot, Giacona-Dahl, 1987;Chan, Lee, Critchley, 1996;Loza Garcia et al, 2000;Zehnder et al, 2004).…”

Section: Books and Internetmentioning

confidence: 99%

Diagnosis of the availability and use of drug information sources in drugstores and pharmacies in southern Brazil

Hennigen

Fischer²,

Camargo

et al. 2009

Braz. J. Pharm. Sci.

View full text Add to dashboard Cite

This research has aimed to estimate the use of drug information sources by pharmacists in drugstores and pharmacies in southern Brazil. It consisted of sending a questionnaire through regular mail, contacting the pharmacist via phone and visiting the drugstores. Four hundred and eight (68.6%) of the 595 enrolled establishments answered the questionnaire. The information at pharmacies and drugstores is searched mainly to orient the patient. At drugstores the professionals have an average of 2.3 books, whereas at pharmacies they rely on 6.1. In a pharmacy, the chance to find more than five books is 27 times higher than in a drugstore. The more often available books are pharmaceutical specialties compendiums. There is access to Internet in 87.5% of pharmacies and 59% of drugstores. The National Agency of Health Surveillance webpage is the most accessed website, and the call centers of Pharmaceutical Companies are the most searched information service. Lack of time is the main alleged difficulty for searching information. The pharmacists working in the studied establishments miss appropriate drug information sources. Taking into consideration how important information is in the pharmaceutical practice, there is a need to emphasize this subject through an educative process, during undergraduate studies and continued education.Uniterms: Pharmaceutical assistance. Drugs/information availability. Pharmaceutical practice.A pesquisa teve como objetivo descrever a utilização de fontes de informação em drogarias e farmácias no sul do Brasil. A mesma consistiu do envio do questionário pelo correio, contato com farmacêuticos por telefone e visita aos estabelecimentos. A resposta foi obtida em 408 (68,6%) dos 595 estabelecimentos amostrados. A informação nas farmácias e drogarias é buscada, principalmente, para orientar o paciente. O profissional tem, em média, 2,3 livros nas drogarias e 6,1 nas farmácias. Em uma farmácia, a chance de se encontrar mais de cinco livros corresponde a 27 vezes aquela em uma drogaria. Os bulários são os livros mais freqüentemente disponíveis. Há acesso à Internet em 87,5% das farmácias e em 59% das drogarias, sendo a chance de uma farmácia ter este recurso, cinco vezes maior que aquela em uma drogaria. A página da Agência Nacional de Vigilância Sanitária é a mais acessada e o Serviço de Atendimento ao Consumidor das Companhias Farmacêuticas, o serviço de informação mais consultado. A falta de tempo é a principal limitação da busca de informação. O farmacêutico nos estabelecimentos pesquisados é carente de fontes adequadas de informação. Considerando a importância da informação na prática farmacêutica, é necessário enfatizar o tema utilizando um processo educativo no período de formação e em atividades de atualização.

show abstract

Section: Books and Internetmentioning

confidence: 99%

Diagnosis of the availability and use of drug information sources in drugstores and pharmacies in southern Brazil

Hennigen

Fischer²,

Camargo

et al. 2009

Braz. J. Pharm. Sci.

View full text Add to dashboard Cite

show abstract

“…11,12 Studies analyzing and comparing the directions and compendia for medications in developed and developing countries have identified differing patterns of information for the same drug from the same multinational. 4,13,14 Although such differences have been observed with regard to directions and compendia, little has been said about the differences in information regarding drug advertising, especially in Brazil.…”

Section: Methodsmentioning

confidence: 99%

Psychoactive drug advertising: a comparison of technical information from three countries: Brazil, United States and United Kingdom

2005

View full text Add to dashboard Cite

CONTEXT AND OBJECTIVE: Studies carried out in the 1970s and 1980s showed that there were country-dependent disparities in the information given for the same drug in medical advertisements. National and international regulations have been published to do away with such disparities and to foster the rational use of drugs. The purpose of this study was to compare the information contained in psychoactive drug advertisements published in psychiatric journals in Brazil, the United States and the United Kingdom, before and subsequent to the publication of the United States Export Act, in 1986, the WHO criteria, in 1988, and the Brazilian Sanitary Surveillance Agency Resolution no. 102, in 2000. TYPE OF STUDY AND SETTING: Content analysis, at Centro Brasileiro de Informações sobre Drogas Psicotrópicas (Cebrid). METHODS: We gathered advertisements from Brazilian, American and British psychiatry periodicals published before and after each ruling. We analyzed a total of twenty-four Brazilian advertisements that were for the same psychoactive drugs as advertised in American and/or British publications from the same period. RESULTS: We observed that Brazilian advertisements omitted information on usage restrictions, such as contraindications, adverse reactions, interactions, warnings and precautions, and that such information was present in American and British advertisements. CONCLUSIONS: The data suggest that disparities in the information given for the same drug still persist. The information depends on the country in which each drug is marketed. The legislation is insufficient for eradicating such disparities.

show abstract

“…Esta não é uma situação isolada, pois estudos realizados por Auricchio, Batistic-Longatto e Nicoletti (2007), Balbani, Stelzer e Montovani (2006) e Barros (2000), demonstraram que as informações veiculadas em rótulos, bulas e no DEF apresentaram sérias deficiências. Isso explica a necessidade de utilização dos sites da ANVISA e dos laboratórios produtores dos medicamentos para obtenção, entre outras, de informações sobre a composição dos produtos.…”

Section: Outras Considerações Importantesunclassified

Presença de excipientes com potencial para indução de reações adversas em medicamentos comercializados no Brasil

Silva¹,

Fonseca²,

Arrais³

et al. 2008

Rev. Bras. Cienc. Farm.

View full text Add to dashboard Cite

show abstract

A (des)informação sobre medicamentos: o duplo padrão de conduta das empresas farmacêuticas

Cited by 31 publications

References 16 publications

Diagnosis of the availability and use of drug information sources in drugstores and pharmacies in southern Brazil

Diagnosis of the availability and use of drug information sources in drugstores and pharmacies in southern Brazil

Psychoactive drug advertising: a comparison of technical information from three countries: Brazil, United States and United Kingdom

Presença de excipientes com potencial para indução de reações adversas em medicamentos comercializados no Brasil

Contact Info

Product

Resources

About